- AI infrastructure provider Accelevation (ACCV.US) pursues U.S. IPO with a maximum valuation of $5.37 billions.
- Bitcoin Rises Ahead of Pezeshkian’s UN Visit: What Comes Next?
- BCH Surpasses $280
- Bank Brades Insider Bought Shares Worth $2,348,116, According to a Recent SEC Filing
- ADP: Private sector weekly average added 20,000 jobs in the four weeks ending September 5
- Star Bulk Carriers Insider Sold Shares Worth $323,400, According to a Recent SEC Filing
- Agat Ejendomme rights issue draws orders for 74,976,732 new shares at DKK 0.72 each
- Palisade Bio wins FDA IND clearance for PALI-2108 Crohn’s disease Phase 2 trial
- Visionary Copper and Gold Mines buys three Newfoundland mineral licenses for C$10,000 cash and C$40,000 in shares
- VistaGen reports positive open-label extension data from PALISADE-4 Phase 3 trial of fasedienol in social anxiety disorder
- Birchtech to present at Gabelli PFAS Symposium
- Idaho Copper wins US Forest Service approval to start drilling at CuMo project in Idaho
- EPH Group plans 300-bed luxury resort development in Austria’s Burgenland region
- Absa Bank updates final redemption timetable for debt note maturing in 2028
- RBC, five Canadian banks explore joint CAD tokenized deposit solution
- Kingsmen Resources hits 218 g/t AgEq over 6.5 meters at Las Coloradas silver project in Mexico
- Fiserv’s Clover partners with Winnipeg Blue Bombers to run venue commerce operations
- Sparta Commercial Services completes two municipal financing deals with Town of Candor, North Carolina
- XFLH Capital signs LOI for business combination with Renogen Biolab
- Sleep Cycle CCO Peter Alsterberg exits; CPO Samuel Cyprian takes over partnerships
- North Atlantic Titanium receives Québec permits to drill Everett titanium-vanadium project
- Quoin Pharma wins FDA fast track status for QRX003 in peeling skin syndrome
- Aon names Jane Drummond global chief commercial officer effective Jan. 1, 2027
- Propanc Biopharma targets February 2027 first-patient dosing for Phase 1b PRP cancer trial
- Superstar Platforms agrees to acquire TitlePal in all-stock deal
- Compass Therapeutics says FDA urges survival-benefit trial before tovecimig BLA in biliary tract cancer
- Choice Properties REIT debentures rated BBB+ by S&P Global Ratings
- Nuburu says closing funds secured for 70% Tekne stake, targets early October close
- Analyst Questions AutoZone's Uptick Following F4Q Results -- Market Talk
- CIBC joins five Canadian banks to explore CAD tokenized deposit initiative
- Columbus McKinnon reprices USD 1.45 billion term loan B, cuts margin 50 bps
- VICI Properties appoints John Sullivan as independent director to board
- Kootenay Silver reports 232 g/t silver over 24 meters at Columba project in Mexico
- Zeo Energy partners with Ewyze to develop off-grid microgrids for data centers
- BMO, five Canadian banks explore joint CAD tokenized deposit solution
- Arcus Biosciences to present new ARC-20 casdatifan data in kidney cancer at Oct. 20 investor event
- --September Philadelphia Fed Regional Nonmanufacturing Activity Index -22.0 Vs. -8.7 Expected, -10.6 Prior
- Tactical Resources begins trading on Nasdaq under TREO after listing completion
- Pagaya closes USD 460 million 24-month revolving personal loan facility
- Marchex targets broader institutional investor engagement with expanded investor relations push
- Pagaya closes USD 460 million revolving personal loan facility
- Upbound Group names Scott Young chief operating officer
- Wall Street expects that Meta's AI assistant will become a new revenue engine.
- Scotiabank, five Canadian peers explore tokenized Canadian-dollar deposit solution
- TD joins five Canadian banks to explore tokenized Canadian-dollar deposit solution
- Superstar Platforms Announces Agreement To Acquire TitlePal, Inc. >SPST
- Tactical Resources outlines next-phase plan to advance Peak rare earths project in Texas
- National Bank of Canada joins five peers to explore secure CAD tokenized deposit solution
- ClearSign CEO to present at Water Tower Research Insights virtual conference
- American Resources’ ReElement unit attends Climate Week NYC, UN General Assembly meetings
- NASDAQ TRADE HALT <VOOB.O> REASON NOT AVAILABLE AT 08:30 AM
- THE WILLIAMS COMPANIES, INC. <WMB.N>: CAPITAL ONE SECURITIES INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $92
- ONEOK, INC. <OKE.N>: CAPITAL ONE SECURITIES INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $110
- KT&G H1 operating profit rises 22.6% YoY to KRW 779 billion; revenue increases 12% to KRW 3.41 trillion
- KBR INC. <KBR.N>: OPPENHEIMER CUTS TARGET PRICE TO $50 FROM $60
- MICROSOFT CORPORATION <MSFT.O>: OPPENHEIMER RAISES TARGET PRICE TO $570 FROM $515
- TYRA BIOSCIENCES INC. <TYRA.O>: OPPENHEIMER CUTS TARGET PRICE TO $40 FROM $50
- KINDER MORGAN, INC. <KMI.N>: CAPITAL ONE SECURITIES INITIATES COVERAGE WITH EQUAL WEIGHT RATING; PRICE TARGET $36
- Cognyte Software Signs $20 Million Security Deal With EMEA Client
- Tradeweb Markets Upgrades Ai-Price to Improve Corporate Bond Execution
- ENERGY TRANSFER LP <ET.N>: CAPITAL ONE SECURITIES INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $26
- Hyliion to dual-list shares on NYSE Texas effective Sept. 22, 2026
- ENTERPRISE PRODUCTS PARTNERS L.P <EPD.N>: CAPITAL ONE SECURITIES INITIATES COVERAGE WITH EQUAL WEIGHT RATING; PRICE TARGET $42
- Dundee Reports Latest Assays from Westhaven's South Zone Deposit in British Columbia
- Bank Brades Insider Bought Shares Worth $842,795, According to a Recent SEC Filing
- Star Bulk director Eleni Vrettou sells 3,500 common shares worth $112,420
- Sun Life to Redeem CA$500 Million of 2.46% Subordinated Debentures
- DigitalBridge Gets Regulatory Approvals to Complete Acquisition by SoftBank
- Greenbrier Gets $600 Million Railcar Orders in Fiscal Q4
- Whale Alert tracks 600 dormant BTC moved after 14 years amid Bitcoin rally
- British Pound: Fiscal squeeze risks dovish BoE – BBH
- NNN REIT, INC. <NNN.N>: MORGAN STANLEY RAISES TO OVERWEIGHT FROM EQUAL WEIGHT
- Accenture, AWS Launch Six Technology, AI Offerings for Mid-Market Companies
- OpenText issues conditional notice to redeem USD 1 billion notes due 2027 on Oct. 2
- LandBridge unit DBR Land Holdings plans USD 100 million add-on 6.25% notes due 2030
- U.S. employment increased by 20,000 in the week ending September 5.
- Viking Therapeutics Says Obesity Drug Showed 'Superior' Results in Study; Shares Jump
- Morgan Stanley Upgrades NNN REIT to Overweight From Equalweight
- Montega cuts Berentzen to hold, sets price target at EUR 5.55
- ADP NER Pulse shows US private employers add 20,000 jobs a week through Sept. 5 (4-week avg)
- Scienture partners with distributor to sell REZENOPY naloxone spray to 2,000 US opioid treatment clinics
- BH Macro posts unaudited August 2026 NAV of USD 4.6 per share, up 0.75% MTD
- Argus Adjusts Price Target on Exelon to $49 From $52, Maintains Buy Rating
- Redfin: US home prices rise 0.25% in August, annual gain hits 3.7%
- LandBridge plans USD 100 million senior notes offering
- Rocket One signs deal to buy Tracer Drone Technologies
- Lexeo Therapeutics to Acquire Mantle Therapeutics for Up to $21.3 Million; Enters Three Research Collaborations
- Rocket One Signs Definitive Agreement To Acquire Revenue-Generating Tracer Drone Technologies, Accelerating AI And Counter-UAS Expansion Across Public Safety And Defense Markets >RKTO
- Siloam Hospitals shareholders approved Rp 6.91 trillion hospital-asset acquisition plan at EGM
- Valion Bio regains Nasdaq compliance with $1 minimum bid price rule
- Canopy Growth Expands European Medical Cannabis Supply Into U.K.
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- BlockchainK2 plans private placement of 1,857,143 shares at $0.07 to raise up to $130,000
- Western Star plans 6,000-foot drill program at Eagle Point tungsten project in New Mexico
- Lantheus wins final FDA approval for BRAVNETSA radiopharmaceutical in GEP-NETs
- TransCode Therapeutics says Australia accepts patent application for siRNA cancer nanoparticle delivery
- FactSet Research: This Deal Is Not Expected to Have a Material Impact on FactSet's Fincl Results >FDS
